Synapse

← Portal hypertension & cirrhosis

Papers in Portal hypertension & cirrhosis

Page 1 · newest first

  1. Albumin for Treatment of Ascites in Patients With CirrhosisPortal hypertension & cirrhosis · 2026
  2. Real‐World Distribution and Mortality Assessment of MDF and MELD Scores in Hospitalized Patients With Alcohol‐Associated Cirrhosis and Clinically Diagnosed Alcohol‐Associated HepatitisPortal hypertension & cirrhosis · 2026
  3. The Emerging Role of China in the Innovation, Individualization, and Translation of Antiviral Therapeutics for Chronic Hepatitis BPortal hypertension & cirrhosis · 2026
  4. Skeletal Muscle Mass Improvement and Survival After TIPS in Patients With Cirrhosis and Low Skeletal Muscle IndexPortal hypertension & cirrhosis · 2026
  5. Recompensation of Cirrhosis: A New Treatment‐Related Disease StatePortal hypertension & cirrhosis · 2026
  6. Author's Reply to “Re‐Evaluating the Comparison of Four Different Ultrasound Elastography Techniques for Diagnosing Advanced Fibrosis”Portal hypertension & cirrhosis · 2026
  7. Recurrent and De Novo Cirrhosis After Liver TransplantationPortal hypertension & cirrhosis · 2026
  8. Epigenetic Regulation of Liver Fibrosis: Mechanisms and Therapeutic ImplicationsPortal hypertension & cirrhosis · 2026
  9. Advances in Viral Markers for Predicting Functional Cure of Chronic Hepatitis BPortal hypertension & cirrhosis · 2026
  10. Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive SolutionsPortal hypertension & cirrhosis · 2026
  11. Correction to “Multifrequency Multiparameter Magnetic Resonance Elastography Applied to an In Vivo Porcine Model for Assessing Portal Hypertension”Portal hypertension & cirrhosis · 2026
  12. Correction to “Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)”Portal hypertension & cirrhosis · 2026
  13. Endoscopic Treatment for Esophagogastric Variceal Bleeding in Patients With Acute‐on‐Chronic Liver Failure: An Observational StudyPortal hypertension & cirrhosis · 2026
  14. Head‐to‐Head Comparison of Four Ultrasound Elastography Techniques in Detecting Advanced FibrosisPortal hypertension & cirrhosis · 2026
  15. A Case of Ileal Conduit Bleeding Caused by Porto‐Sinusoidal Vascular DisorderPortal hypertension & cirrhosis · 2026
  16. Preclinical Efficacy and Safety Evaluation of a Novel Controlled‐Expansion ePTFE‐Covered TIPS Stent in a Swine ModelPortal hypertension & cirrhosis · 2026
  17. When Fat Goes Astray: Your Liver and Pancreas Get Into TroublePortal hypertension & cirrhosis · 2026
  18. Comparable Diagnostic Accuracy but Discordant Thresholds Between FibroTouch and FibroScan: A Biopsy‐Based Comparative StudyPortal hypertension & cirrhosis · 2026
  19. Current Cell/Organoid and Animal Models for Primary Sclerosing CholangitisPortal hypertension & cirrhosis · 2026
  20. Sono‐Vasomics With Super‐Resolution Contrast‐Enhanced Ultrasound (SR‐CEUS) for Characterization of Focal Liver Lesions: A Case ReportPortal hypertension & cirrhosis · 2026
  21. Microbubble‐Based Ultrasound Contrast Agents in Contrast‐Enhanced Ultrasonography for Managing Portal Hypertension in CirrhosisPortal hypertension & cirrhosis · 2026
  22. Severe Thrombocytopenia Is Associated With Bleeding in Hepatocellular Carcinoma Patients Receiving Antiangiogenic TherapyPortal hypertension & cirrhosis · 2026
  23. Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management ImplicationsPortal hypertension & cirrhosis · 2026
  24. The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver CirrhosisPortal hypertension & cirrhosis · 2026
  25. The Safety of Interferon‐Based Therapies in Chronic Hepatitis B Patients With Compensatory CirrhosisPortal hypertension & cirrhosis · 2026
  26. Fast Quantitative Evaluation of the Amelioration Effect in MASLD During Semaglutide Treatment Using Ultrasound‐Derived Fat Fraction and Fat‐to‐Muscle RatioPortal hypertension & cirrhosis · 2026
  27. Liver Fibrosis Tests and Outcomes of Bariatric Surgery in Morbidly Obese Patients With MASLDPortal hypertension & cirrhosis · 2026
  28. Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic StudyPortal hypertension & cirrhosis · 2026
  29. Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver DiseasePortal hypertension & cirrhosis · 2026
  30. Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)Portal hypertension & cirrhosis · 2026
  31. From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic StrategiesPortal hypertension & cirrhosis · 2026
  32. Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1Portal hypertension & cirrhosis · 2026
  33. Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021Portal hypertension & cirrhosis · 2026
  34. The Use of Non‐Selective Beta‐Blockers in Cirrhotic Portal HypertensionPortal hypertension & cirrhosis · 2026
  35. Multifrequency Multiparameter Magnetic Resonance Elastography Applied to an In Vivo Porcine Model for Assessing Portal HypertensionPortal hypertension & cirrhosis · 2026
  36. Predictive Value of Coagulation Factor VIII and Protein C Levels for Further Decompensated Events in Patients With Decompensated CirrhosisPortal hypertension & cirrhosis · 2025
  37. Artificial Liver Therapy Ameliorates Hepatitis B Virus–Related Acute‐on‐Chronic Liver Failure by Remodeling the Microbiota StructurePortal hypertension & cirrhosis · 2025
  38. Radiological Organ Age Reveals Accelerated Aging of the Liver and Spleen by Liver FibrosisPortal hypertension & cirrhosis · 2025
  39. Liver Cirrhosis and Sleep DisordersPortal hypertension & cirrhosis · 2025
  40. Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma Located at Esophageal Varices Caused by Liver CirrhosisPortal hypertension & cirrhosis · 2025
  41. Advances in the Diagnosis, Treatment, and Management of Liver Nodules: A Comprehensive ReviewPortal hypertension & cirrhosis · 2025
  42. Advances in the Diagnosis, Treatment, and Management of Liver Nodules: A Comprehensive ReviewPortal hypertension & cirrhosis · 2025
  43. Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic ShuntPortal hypertension & cirrhosis · 2025
  44. Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic ShuntPortal hypertension & cirrhosis · 2025
  45. Epidemiological Characteristics of Acute‐on‐Chronic Liver Failure in Patients With Compensated Liver Disease: A Systematic Review and Meta‐AnalysisPortal hypertension & cirrhosis · 2025
  46. Deep Learning‐Based Prediction of High‐Risk Gastroesophageal Varices Using Two‐Dimensional Shear Wave ElastographyPortal hypertension & cirrhosis · 2025
  47. The Interplay Between Alcohol Consumption and Cardiometabolic Risk Factors in Individuals With MASLD and MetALDPortal hypertension & cirrhosis · 2025
  48. Liver Cirrhosis Secondary to Overlap Autoimmune Liver Disease as the Initial Presentation of Sjögren's SyndromePortal hypertension & cirrhosis · 2025
  49. Serum Creatinine of 1.1 mg/dL Can Indicate Disease Deterioration and 90‐day Mortality in Hospitalized Patients With Cirrhosis in Chinese PopulationPortal hypertension & cirrhosis · 2025
  50. The Role of Magnesium in Liver CirrhosisPortal hypertension & cirrhosis · 2025